California Supreme Court allows “pay-to-delay” suit to proceed

Consumer Law and Policy Blog reports that the California Supreme Court has revived antitrust suits against Bayer and Barr Laboratories. The cases stem from an agreement between brand-name manufacturer Bayer and generic manufacturer Barr, under which Bayer agreed to pay Barr $398.1 million in exchange for Barr postponing the sale of the generic version of Bayer’s antibiotic Cipro. Such agreements, called “pay-to-delay” agreements, have been frequently challenged under the antitrust laws.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s